• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Sagent Pharmaceuticals

edit

Sagent Pharmaceuticals is a privately held specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients. Sagent currently has more than 200 products in development.

Recent Milestones

edit

• 
  Sagent Pharmaceuticals received $40M in Series B funding. (4/8/10)
  Posted 4/8/10 at 4:29pm via fiercebiotech.com
• 
  Sagent Pharmaceuticals received $30M in Series A funding. (6/14/09)
  Posted 6/15/09 at 8:26am via onbiovc.com
• 
  Sagent Pharmaceuticals added Sudheer Thakur as Senior Engineer. (1/1/98)
  Posted 5/23/13 at 2:20pm

Videos

Screenshots

edit

Above: Home Page
Uploaded: 6/15/09

Sources

1. Sagent Pharmaceuticals, Inc.: Series A $30M (onbiovc.com) [edit]
2. Sagent raises $40M, increases reach in China (fiercebiotech.com) [edit]